Sh Fosun Pharma reported CNY3.27B in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Cspc Pharmaceutical CNY 1.87B 95.62M Dec/2025
Jiangsu Hengrui CNY 2.81B 191.05M Mar/2026
Kangmei Pharma CNY 237.06M 37.35M Mar/2026
Sh Pharmaceutical CNY 5.03B 372.15M Dec/2025
Sino Biopharmaceutical CNY 7.54B 2.23B Jun/2025
Wuxi Apptec CNY 891.8M 147.89M Mar/2026
Zz Pientze Pharmaceu CNY 214.31M 42.4M Mar/2026